Iceland· IS-970130
Soluprick SQ (House Dust Mites)
A tests for allergic diseases product containing dermatophagoides pteronyssinus,dermatophagoides farinae, registered in Iceland by ALK-Abelló A/S. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Dermatophagoides pteronyssinus,dermatophagoides farinae is registered in 11 of 19 countries.
Countries holding a registration under ATC V04CL (tests for allergic diseases), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Dermatophagoides pteronyssinus,dermatophagoides farinae · ATC V04CL
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Dermatophagoides pteronyssinus,Dermatophagoides farinae
- Manufacturer
- ALK-Abelló A/S
- Country
- Iceland (IS)
- ATC code
- V04CL
- ATC class
- Tests for allergic diseases
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dermatophagoides pteronyssinus,dermatophagoides farinae in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesOdactraALK-Abello A S
- SwedenAcarizax 12 SQ-HDM Frystorkad sublingual tablettMedartuum AB
- NorwayAcarizaxALK-Abelló AS
- IrelandACARIZAX 12 SQ-HDM sublingual lyophilisateALK-Abello A/S
- GermanyAcarizaxAlk-Abello A/S
- SpainACARIZAX 12 SQ-HDM LIOFILIZADO SUBLINGUALAlk-Abello A/S
- CanadaACARIZAXALK-ABELLO A/S
- FinlandAcarizaxALK-Abello A/S
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Acarizax, Actair
- Belgium · Acarizax, Orylmyte
- Bulgaria · Актаир, Алиостал Прик, Алергенен Екстракт От Микрокърлежи
- Czechia · Acarizax, Actair
- Germany · Acarizax, Aitaro
- Denmark · Acarizax, Aitmyte
- Spain · Acarizax, Actair
- Finland · Acarizax
- France · Acarizax, Dusetlis
- United Kingdom (Northern Ireland) · Acarizax, Actair
- Croatia · Acarizax, Orylmyte
- Hungary · Acarizax, Staloral
- Ireland · Acarizax, Actair
- Italy · Accarizax, Orylmyte
- Luxembourg · Acarizax, Orylmyte
- Netherlands · Acarizax, Actair
- Norway · Acarizax, Aitmyte
- Poland · Acarizax, Actair
- Portugal · Actair
- Romania · Acarizax, Actair
- Sweden · Acarizax, Aitmyte
- Slovenia · Acarizax, Actair
- Slovakia · Acarizax, Actair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0c0eb9e-6a3e-4e96-9689-8d0eddfdaff4 GET /v1/drugs/c0c0eb9e-6a3e-4e96-9689-8d0eddfdaff4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Húðstungupróf, lausn",
"source": "lyfjastofnun",
"atc_raw": "V04CL",
"marketed": true,
"strength": "10 HEP",
"ma_number": "970130",
"substance": "Dermatophagoides pteronyssinus,Dermatophagoides farinae",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "36294"
}See everything about dermatophagoides pteronyssinus,dermatophagoides farinae.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.